Clinical trials
Obesity trials in Singapore with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 7 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 6 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Unknown status | 11 |
| Recruiting | 5 |
| Active, not recruiting | 4 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Singapore Institute of Food and Biotechnology Innovation | 14 |
| National University Hospital, Singapore | 6 |
| KK Women's and Children's Hospital | 4 |
| Nanyang Technological University | 4 |
| Duke-NUS Graduate Medical School | 3 |
| National University Health System, Singapore | 2 |
| National University of Singapore | 2 |
| Sengkang General Hospital | 2 |
| Alexandra Hospital | 1 |
| Changi General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 44 |
| Overweight | 10 |
| Diabetes Mellitus, Type 2 | 9 |
| Diabetes Mellitus | 7 |
| Glucose Intolerance | 6 |
| Weight Loss | 4 |
| Metabolic Diseases | 3 |
| Prediabetic State | 3 |
| Hypertension | 2 |
| Insulin Resistance | 2 |
Trials
Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.